| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.51 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |